# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-19-006402
Filing Date
2019-04-15
Accepted
2019-04-15 16:46:40
Documents
6
Period of Report
2019-05-16
Effectiveness Date
2019-04-15

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFINITIVE PROXY STATEMENT | def14a0419_endralife.htm | DEF 14A | 642227
2 | GRAPHIC | endralife_logo.jpg | GRAPHIC | 115211
3 | GRAPHIC | sign001.jpg | GRAPHIC | 17903
4 | GRAPHIC | endralife_logo1.jpg | GRAPHIC | 115234
5 | GRAPHIC | sign002.jpg | GRAPHIC | 13609
6 | GRAPHIC | proxy_1.jpg | GRAPHIC | 712041
| Complete submission text file | 0001213900-19-006402.txt |  | 1960010

Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

EIN.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37969 | Film No.: 19749052
SIC: 3845 Electromedical & Electrotherapeutic Apparatus